Search Orphan Drug Designations and Approvals
-
Generic Name: | chimeric IgG4 monoclonal antibody targeting CD14 |
---|---|
Date Designated: | 01/11/2021 |
Orphan Designation: | Treatment of amyotrophic lateral sclerosis |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Implicit Bioscience Ltd. 32 Logan Rd Woolloongabba , Queensland Australia The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-